Abbott news and events in 2026
Abbott is a global healthcare leader that helps people live more fully at all stages of life. Our portfolio of life-changing technologies spans the spectrum of healthcare, with leading businesses and products in diagnostics, medical devices, nutritional and branded generic medicines.
Public (ABT)Software Development10,000+ employeesabbott.comLinkedIn
- Dated updates
- 99
- Last event
- Sep 29, 2026
- Open rolesSnapshot Sep 29, 2026
- 472
- Latest SEC filing
- Aug 20, 2026
Overview
Abbott by topic
110-K filing
472open roles
1executive move
53+signals
40 in the last 90 days
- Glassdoor15+
- LinkedIn15+
- Website changes15+
- Patents6
- and 2 more sources
Latest events
Latest Abbott events
Showing 10 of 39 events. The Signal API returns all of them.
Get them with one API call- RecognitionAbbott declares 411th consecutive quarterly dividendAbbott is a member of the S&P 500 Dividend Aristocrats Index, which tracks companies that have increased dividends annually for at least 25 consecutive years.
- LaunchAbbott Pacemaker Receives FDA ApprovalAbbott's AVEIR VR Mini Ventricular leadless pacemaker (LP) has received approval from the U.S. Food & Drug Administration.
- PartnershipAbbott partners with Sengkang General Hospital to advance early detection of muscle loss in SingaporeAbbott and Sengkang General Hospital (SKH) have announced a new three-year collaboration to expand muscle health screening, training and public education efforts across Singapore.
- LaunchAbbott receives FDA approval for its TactiFlex™ Duo Ablation Catheter to treat people with abnormal heart rhythmsWith U.S. Food and Drug Administration
- LaunchAbbott Unveils First Whole Milk Ready-To-Feed Infant Formula In U.S.Abbott has launched Similac 360 Total Care Made With Whole Milk, the first and only ready-to-feed liquid infant formula in the United States made with whole milk.
- Integration
- In developmentAbbott receives FDA authorization for world's first dual glucose-ketone sensing technology for people with diabetesAbbott announced that the U.S. Food and Drug Administration (FDA) has authorized its Libre Duo 10 Day system, the world's first dual glucose-ketone sensing technology, which it plans to launch in the United States later in 2026.
- LaunchAbbott receives FDA authorization for world's first dual glucose-ketone sensing technology for people with diabetesAbbott received U.S. Food and Drug Administration (FDA) authorization for its Libre Duo 10 Day system, the world's first dual glucose-ketone sensing technology for people with diabetes.
- PartnershipAbbott partners with other companies to raise awareness about the importance of clinical nutrition in cancer treatment.Abbott is collaborating with the medical community in Vietnam to promote knowledge and raise awareness about the role of comprehensive care and nutrition in cancer treatment.
- New customer
Showing 10 of 39 events. The Signal API returns all of them.
Get them with one API callSignal API · MCP
Track Abbott with the Signal API
One POST /v1/companies/enrich call with abbott.com returns every signal type for Abbott, each with its source. Or ask Claude through MCP.
2 credits per signal returned; zero-result calls are free. Endpoint reference
curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{"domain":"abbott.com","limit":20}'Same industry
Companies related to Abbott
Abbott questions
What is the latest news on Abbott?
What is going on with Abbott?
What else does Autobound track for Abbott?
Is Abbott hiring right now?
Source. News, SEC filings (8-K, 10-K, 10-Q, Form D), hiring data and other signals (Reddit, podcasts, Glassdoor, reviews, social posts, patents, web traffic) from the Autobound Signal API.
Method. Stories are grouped when they report the same event within 14 days. Rows that do not name the company are removed. Each row links its source.
Data as of .